Substance or medication-induced anxiety disorder

Revision as of 19:02, 10 November 2014 by Kiran Singh (talk | contribs)
Jump to navigation Jump to search

WikiDoc Resources for Substance or medication-induced anxiety disorder

Articles

Most recent articles on Substance or medication-induced anxiety disorder

Most cited articles on Substance or medication-induced anxiety disorder

Review articles on Substance or medication-induced anxiety disorder

Articles on Substance or medication-induced anxiety disorder in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Substance or medication-induced anxiety disorder

Images of Substance or medication-induced anxiety disorder

Photos of Substance or medication-induced anxiety disorder

Podcasts & MP3s on Substance or medication-induced anxiety disorder

Videos on Substance or medication-induced anxiety disorder

Evidence Based Medicine

Cochrane Collaboration on Substance or medication-induced anxiety disorder

Bandolier on Substance or medication-induced anxiety disorder

TRIP on Substance or medication-induced anxiety disorder

Clinical Trials

Ongoing Trials on Substance or medication-induced anxiety disorder at Clinical Trials.gov

Trial results on Substance or medication-induced anxiety disorder

Clinical Trials on Substance or medication-induced anxiety disorder at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Substance or medication-induced anxiety disorder

NICE Guidance on Substance or medication-induced anxiety disorder

NHS PRODIGY Guidance

FDA on Substance or medication-induced anxiety disorder

CDC on Substance or medication-induced anxiety disorder

Books

Books on Substance or medication-induced anxiety disorder

News

Substance or medication-induced anxiety disorder in the news

Be alerted to news on Substance or medication-induced anxiety disorder

News trends on Substance or medication-induced anxiety disorder

Commentary

Blogs on Substance or medication-induced anxiety disorder

Definitions

Definitions of Substance or medication-induced anxiety disorder

Patient Resources / Community

Patient resources on Substance or medication-induced anxiety disorder

Discussion groups on Substance or medication-induced anxiety disorder

Patient Handouts on Substance or medication-induced anxiety disorder

Directions to Hospitals Treating Substance or medication-induced anxiety disorder

Risk calculators and risk factors for Substance or medication-induced anxiety disorder

Healthcare Provider Resources

Symptoms of Substance or medication-induced anxiety disorder

Causes & Risk Factors for Substance or medication-induced anxiety disorder

Diagnostic studies for Substance or medication-induced anxiety disorder

Treatment of Substance or medication-induced anxiety disorder

Continuing Medical Education (CME)

CME Programs on Substance or medication-induced anxiety disorder

International

Substance or medication-induced anxiety disorder en Espanol

Substance or medication-induced anxiety disorder en Francais

Business

Substance or medication-induced anxiety disorder in the Marketplace

Patents on Substance or medication-induced anxiety disorder

Experimental / Informatics

List of terms related to Substance or medication-induced anxiety disorder

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Overview

Differential Diagnosis

Epidemiology and Demographics

Prevalence

The prevalence of substance or medication-induced anxiety disorder is not clear in the overall population.[1]

Diagnostic Criteria

DSM-V Diagnostic Criteria for Substance/Medication-Induced Anxiety Disorder [1]

AND

  • B.There is evidence from the history, physical examination, or laboratory findings of both (1)and (2):
  • 1.The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication.
  • 2.The involved substance/medication is capable of producing the symptoms in Criterion A.

AND

  • C.The disturbance is not better explained by an anxiety disorder that is not substance/medication-induced. Such evidence of an independent anxiety disorder could include

the following:

  • The symptoms precede the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute withdrawal or severe intoxication: or there is other evidence suggesting the existence of an independent non-substance/medication-induced anxiety disorder

(e.g., a history of recurrent non-substance/medication-related episodes).

AND

  • D.The disturbance does not occur exclusively during the course of a delirium.

AND

  • E.The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.

Note:This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and they are sufficiently severe to warrant clinical attention .

References

  1. 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.


Template:WikiDoc Sources